Flavin Financial Services’s AbbVie ABBV Stock Holding History

Flavin Financial Services’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$645K	Buy	2,563 +595	+30%	+$128K	0.37%	54
2026 Q1	$428K	Buy	1,968 +108	+6%	+$24K	0.29%	60
2025 Q4	$425K	Sell	1,860 -100	-5%	-$22.8K	0.29%	59
2025 Q3	$454K	Hold	1,960	–	–	0.32%	57
2025 Q2	$364K	Hold	1,960	–	–	0.35%	59
2025 Q1	$411K	Hold	1,960	–	–	0.38%	58
2024 Q4	$348K	Buy	+1,960	New	+$360K	0.33%	59

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Flavin Financial Services's ABBV Position: Q2 2026 in Review

Flavin Financial Services increased its AbbVie (ABBV) stake by 30% in Q2 2026, buying an estimated $128K and bringing the position to 2,563 shares worth $645K. The position accounts for 0.37% of the portfolio, ranked #54.

Flavin Financial Services first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Flavin Financial Services held 2,563 shares of AbbVie worth $645K as of Q2 2026.
Flavin Financial Services bought 595 AbbVie shares in Q2 2026, an estimated $128K.
AbbVie made up 0.37% of Flavin Financial Services's portfolio in Q2 2026, its #54 holding.
Flavin Financial Services first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Flavin Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.